Related Experiment Video
Updated: Apr 1, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.5K
Bradysomnia in Parkinson's disease.
Lukas L Imbach1, Michael Sommerauer1, Rositsa Poryazova1
1Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.
Summary
Parkinson's disease (PD) patients exhibit altered sleep microstructure. Our study found reduced sleep-wake dynamics in PD, measured by state space velocity, suggesting a potential biomarker for sleep changes.
Area of Science:
- Neuroscience
- Sleep Medicine
- Computational Biology
Background:
- Polysomnography in Parkinson's disease (PD) reveals altered sleep microstructure and reduced arousability.
- These findings suggest impaired sleep-wake dynamics in individuals with PD.
Purpose of the Study:
- To investigate the dynamical aspects of sleep electroencephalography (EEG) in PD patients compared to healthy controls.
- To quantify sleep EEG spectral variability using a state space model.
Main Methods:
- A retrospective, controlled study involving 64 PD patients and matched healthy volunteers.
- Application of a state space model for sleep EEG analysis.
- Quantification of spectral variability via state space velocity to assess sleep dynamics.
Main Results:
- State space analysis indicated preserved global sleep-wake architecture in PD patients.
- A significant reduction in the velocity of sleep stage transitions was observed in PD patients compared to controls.
- State space velocity strongly correlated with arousal scores and dopamine agonist intake.
Conclusions:
- Quantitative analysis of spectral sleep EEG variability (state space velocity) demonstrates reduced sleep-wake dynamics in PD patients.
- State space velocity is proposed as an objective biomarker for altered sleep microstructure in PD, offering insights beyond conventional analysis.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
REM Sleep Behavior Disorder
2.5K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.5K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Decreased pulse rate
1.0K
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
1.0K
Management of Insomnia
781
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
781
Narcolepsy
780
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
780

